These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7940998)

  • 21. Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors.
    Feoktistov I; Ryzhov S; Goldstein AE; Biaggioni I
    Circ Res; 2003 Mar; 92(5):485-92. PubMed ID: 12600879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat.
    Hannon JP; Pfannkuche HJ; Fozard JR
    Br J Pharmacol; 1995 Jul; 115(6):945-52. PubMed ID: 7582525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of fMLP-triggered respiratory burst of human monocytes by adenosine: involvement of A3 adenosine receptor.
    Broussas M; Cornillet-Lefèbvre P; Potron G; Nguyen P
    J Leukoc Biol; 1999 Sep; 66(3):495-501. PubMed ID: 10496321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine receptors and their modulators.
    Müller CE; Scior T
    Pharm Acta Helv; 1993 Sep; 68(2):77-111. PubMed ID: 8234392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release.
    Ezeamuzie CI; Philips E
    Br J Pharmacol; 1999 May; 127(1):188-94. PubMed ID: 10369472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis.
    Gao Z; Li BS; Day YJ; Linden J
    Mol Pharmacol; 2001 Jan; 59(1):76-82. PubMed ID: 11125027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
    Zhou QY; Li C; Olah ME; Johnson RA; Stiles GL; Civelli O
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7432-6. PubMed ID: 1323836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of adenosine A2 alpha receptors inhibits mast cell degranulation and mast cell-dependent vasoconstriction.
    Fenster MS; Shepherd RK; Linden J; Duling BR
    Microcirculation; 2000 Apr; 7(2):129-35. PubMed ID: 10802855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.
    Pugliese AM; Latini S; Corradetti R; Pedata F
    Br J Pharmacol; 2003 Sep; 140(2):305-14. PubMed ID: 12970092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine receptors and their ligands.
    Klotz KN
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):382-91. PubMed ID: 11111832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and function of adenosine receptors and their genes.
    Fredholm BB; Arslan G; Halldner L; Kull B; Schulte G; Wasserman W
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):364-74. PubMed ID: 11111830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells.
    Suh BC; Kim TD; Lee JU; Seong JK; Kim KT
    Br J Pharmacol; 2001 Sep; 134(1):132-42. PubMed ID: 11522605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.
    Liu GS; Richards SC; Olsson RA; Mullane K; Walsh RS; Downey JM
    Cardiovasc Res; 1994 Jul; 28(7):1057-61. PubMed ID: 7954592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2).
    Feoktistov I; Garland EM; Goldstein AE; Zeng D; Belardinelli L; Wells JN; Biaggioni I
    Biochem Pharmacol; 2001 Nov; 62(9):1163-73. PubMed ID: 11705449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicinal chemistry of adenosine A3 receptor ligands.
    Müller CE
    Curr Top Med Chem; 2003; 3(4):445-62. PubMed ID: 12570761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.
    Feoktistov I; Biaggioni I
    Biochem Pharmacol; 1998 Mar; 55(5):627-33. PubMed ID: 9515573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
    Linden J; Thai T; Figler H; Jin X; Robeva AS
    Mol Pharmacol; 1999 Oct; 56(4):705-13. PubMed ID: 10496952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [125I]4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I)AB-MECA) labels multiple adenosine receptor subtypes in rat brain.
    Shearman LP; Weaver DR
    Brain Res; 1997 Jan; 745(1-2):10-20. PubMed ID: 9037389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cDNA cloning and characterization of A3i, an alternatively spliced rat A3 adenosine receptor variant.
    Sajjadi FG; Boyle DL; Domingo RC; Firestein GS
    FEBS Lett; 1996 Mar; 382(1-2):125-9. PubMed ID: 8612733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.